MEHCQ — 23andMe Holding Co Income Statement
0.000.00%
- $134.95m
- $96.71m
- $189.90m
- 49
- 41
- 50
- 44
Annual income statement for 23andMe Holding Co, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | R2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 244 | 272 | 299 | 220 | 190 |
Cost of Revenue | |||||
Gross Profit | 117 | 133 | 132 | 97.9 | 100 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 429 | 526 | 523 | 801 | 433 |
Operating Profit | -185 | -254 | -223 | -582 | -243 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -184 | -221 | -213 | -567 | -235 |
Provision for Income Taxes | |||||
Net Income After Taxes | -184 | -217 | -211 | -567 | -235 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -184 | -217 | -312 | -667 | -281 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -184 | -217 | -312 | -667 | -281 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -84.3 | -12 | -9.05 | 34.2 | -6.98 |